Evidence map›Paper›PMID 41816690›Full record

ArticleFrontiers in microbiology2026

Genomic insights into multidrug resistance in clinical

Peihua Zhang, Xi Yang, Qian Liu, Xinxia Sui, Wang Zhang, Yanwen Xiong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Peihua ZhangNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Xi YangNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Qian LiuNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Xinxia SuiNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Wang ZhangNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Yanwen XiongNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: We performed whole-genome sequencing on strain ESA311 to identify plasmids, resistance genes, and virulence factors. Conjugation experiments were conducted to evaluate plasmid transferability. Phylogenetic analysis of the MDR plasmids elucidated their evolutionary history and geographical distribution. The prevalence of Results: Whole-genome sequencing identified five plasmids coexisting in ESA311, with pESA311_1 and pESA311_2 harboring diverse antimicrobial resistance genes (ARGs) conferring resistance to seven antibiotic classes, facilitated by mobile genetic elements including insertion sequences (ISs) and a class 1 integron ( Conclusion: Our findings establish plasmids and

Indexed as

antimicrobial resistanceclass I integronconjugative plasmidsEscherichia albertiiplasmid evolution

Identifiers

PMID41816690
PMCPMC12971918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.